Quantitative studies on antibiotic nephrotoxicity.
D000328:Adult; D000368:Aged; D000583:Amikacin / Q000009:adverse effects / Q000031:analogs & derivatives; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002440:Cefoxitin / Q000009:adverse effects; D002444:Cefuroxime / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000009:adverse effects; D005260:Female; D005839:Gentamicins / Q000009:adverse effects; D005919:Glomerular Filtration Rate / Q000187:drug effects*; D006801:Humans; D007687:Kidney Tubules, Proximal / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D013420:Sulfamethoxazole / Q000009:adverse effects; D014295:Trimethoprim / Q000009:adverse effects; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D001613:beta 2-Microglobulin / Q000032:analysis
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005839:Gentamicins; D001613:beta 2-Microglobulin; D002440:Cefoxitin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000583:Amikacin; D014295:Trimethoprim; C016924:butikacin; D013420:Sulfamethoxazole; D002444:Cefuroxime